|
CISD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.6621374255883E-15 |
| Normal-vs-Stage2 |
7.8143000000086E-05 |
| Normal-vs-Stage3 |
1.369900E-04 |
| Normal-vs-Stage4 |
2.770900E-04 |
| Stage1-vs-Stage2 |
7.822200E-01 |
| Stage1-vs-Stage3 |
4.457200E-01 |
| Stage1-vs-Stage4 |
2.027800E-01 |
| Stage2-vs-Stage3 |
4.774400E-01 |
| Stage2-vs-Stage4 |
2.637800E-01 |
| Stage3-vs-Stage4 |
7.258200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.662400E-03 |
| Normal-vs-Asian |
1.903760E-01 |
| Caucasian-vs-AfricanAmerican |
2.701900E-02 |
| Caucasian-vs-Asian |
5.473500E-02 |
| AfricanAmerican-vs-Asian |
6.082000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29550004057677E-09 |
| Normal-vs-Female |
1.62825308791525E-12 |
| Male-vs-Female |
2.610600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.319600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.51450029873513E-11 |
| Normal-vs-Age(61-80Yrs) |
2.63677968348475E-12 |
| Normal-vs-Age(81-100Yrs) |
4.117200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.340100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.181320E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.622400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.648000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.586440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.157400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.879300E-03 |
| Normal-vs-Grade 2 |
6.78457290348433E-12 |
| Normal-vs-Grade 3 |
5.12080378101132E-11 |
| Normal-vs-Grade 4 |
3.818800E-03 |
| Grade 1-vs-Grade 2 |
8.437000E-01 |
| Grade 1-vs-Grade 3 |
3.450000E-01 |
| Grade 1-vs-Grade 4 |
7.704400E-02 |
| Grade 2-vs-Grade 3 |
1.204840E-01 |
| Grade 2-vs-Grade 4 |
4.899200E-03 |
| Grade 3-vs-Grade 4 |
9.471800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
4.100000E-03 |
| ccA subtype-vs-ccB subtype |
6.81999999807559E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53108645154043E-12 |
| Normal-vs-N1 |
6.682000E-02 |
| N0-vs-N1 |
2.182400E-01 |
|
|
